Methods | Randomised controlled trial of individual women in low-income setting | |
---|---|---|
Participants |
Setting: Sousse, Tunisia. Low-income country. Women with singleton pregnancies expecting to give birth vaginally Exclusion criteria: placenta praevia, APH, non-cephalic presentation, intrauterine death, parity > 5, uterine fibroids, anticoagulation therapy, history of PPH, history of CS |
|
Interventions |
Intervention: active management of 3rd stage (N = 65):
Data included in Comparison 12 |
|
Outcomes | Pre-specified: reduction in HCT and Hb. | |
Notes | We contacted the authors again on 14th March 2011, for further information on the management in the comparison arm, the methodology they used and data obtained. Reply received 19th March 2011. No publication has emanated, no further data were provided, but methodology was clarified | |
Risk of bias | ||
Bias | Authors’ judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | As per www.randomization.com (not stated in publication but information provided by author on 19 March 2011) |
Allocation concealment (selection bias) | High risk | Not concealed in any way (not stated in publication, but in information provided by author on 19 March 2011) |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No loss described in publication and confirmed by information from author on 19 March 2011. Authors also provided information that the analysis was by ‘intention to treat’ |
Selective reporting (reporting bias) | Unclear risk | We did not assess the trial protocol. |
Other bias | Unclear risk | Women reported to have been allocated to groups after placental delivery yet active management group supposedly had oxy-tocin with the anterior shoulder |